Document is current
Any future updates will be listed below
-
Authors
Ji, Changhua
Kumpf, Steven
Qian, Jessie
Federspiel, Joel D.
Sheehan, Mark
Capunitan, Darien
Atallah, Edmond
Astbury, Stuart
Arat, Seda
Oziolor, Elias
Ocana, Mireia Fernandez
Ramaiah, Shashi K.
Grove, Jane
Aithal, Guruprasad P.
Lanz, Thomas A.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04476563 at ClinicalTrials.govDocuments that mention this clinical trial
Transcriptomic and proteomic characterization of cell and protein biomarkers of checkpoint inhibitor-induced liver injury
https://doi.org/10.1007/s00262-025-04033-z
-
Funding
Funding for this research was provided by:
Pfizer
- License Information
-
More Information
Article History
Received: 27 January 2025
Accepted: 24 March 2025
First Online: 3 May 2025
Declarations
:
: CJ, SK, JQ, JDF, MS, DC, Seda A, EO, MFO, SKR, and TAL are Pfizer employees.
